These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34688535)

  • 1. Advanced glycation end products via skin autofluorescence as potential marker of carotid atherosclerosis in patients with type 2 diabetes.
    Ying L; Shen Y; Zhang Y; Wang Y; Liu Y; Yin J; Wang Y; Yin J; Zhu W; Bao Y; Zhou J
    Nutr Metab Cardiovasc Dis; 2021 Nov; 31(12):3449-3456. PubMed ID: 34688535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Advanced Glycation End Products With Lower-Extremity Atherosclerotic Disease in Type 2 Diabetes Mellitus.
    Ying L; Shen Y; Zhang Y; Wang Y; Liu Y; Yin J; Wang Y; Yin J; Zhu W; Bao Y; Zhou J
    Front Cardiovasc Med; 2021; 8():696156. PubMed ID: 34568445
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of skin autofluorescence with low bone density/osteoporosis and osteoporotic fractures in type 2 diabetes mellitus.
    Liu H; Wang G; Wu T; Hu J; Mu Y; Gu W
    J Diabetes; 2022 Sep; 14(9):571-585. PubMed ID: 36058895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin autofluorescence as a measure of advanced glycation end product levels is associated with carotid atherosclerotic plaque burden in an elderly population.
    Jujić A; Östling G; Persson M; Engström G; Nilsson PM; Melander O; Magnusson M
    Diab Vasc Dis Res; 2019 Sep; 16(5):466-473. PubMed ID: 31064217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of advanced glycation end products with ear lobe crease: A cross-sectional study.
    Wang Y; Xin Y; Li B; Wu Q; An P; Li B; Li Y; Zang L; Gu W; Mu Y
    J Diabetes; 2024 Apr; 16(4):e13548. PubMed ID: 38599828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive Measurement of Skin Autofluorescence as a Beneficial Surrogate Marker for Atherosclerosis in Patients with Type 2 Diabetes.
    Temma J; Matsuhisa M; Horie T; Kuroda A; Mori H; Tamaki M; Endo I; Aihara K; Abe M; Matsumoto T
    J Med Invest; 2015; 62(3-4):126-9. PubMed ID: 26399335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin autofluorescence, a measure of tissue accumulation of advanced glycation end products, is associated with subclinical atherosclerosis in coronary and carotid arteries.
    Pan J; Bao X; Gonçalves I; Jujić A; Engström G
    Atherosclerosis; 2022 Mar; 345():26-32. PubMed ID: 35196628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Subclinical Atherosclerosis Markers and the Level of Accumulated Advanced Glycation End-Products in the Skin of Patients with Diabetes.
    Ninomiya H; Katakami N; Sato I; Osawa S; Yamamoto Y; Takahara M; Kawamori D; Matsuoka TA; Shimomura I
    J Atheroscler Thromb; 2018 Dec; 25(12):1274-1284. PubMed ID: 29962379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of advanced glycation end products with diabetic retinopathy in type 2 diabetes mellitus.
    Ying L; Shen Y; Zhang Y; Wang Y; Liu Y; Yin J; Wang Y; Yin J; Zhu W; Bao Y; Zhou J
    Diabetes Res Clin Pract; 2021 Jul; 177():108880. PubMed ID: 34058298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end-products, measured as skin autofluorescence, associate with vascular stiffness in diabetic, pre-diabetic and normoglycemic individuals: a cross-sectional study.
    Birukov A; Cuadrat R; Polemiti E; Eichelmann F; Schulze MB
    Cardiovasc Diabetol; 2021 Jun; 20(1):110. PubMed ID: 34176469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are Advanced Glycation End Products in Skin Associated with Vascular Dysfunction Markers? A Meta-Analysis.
    Saz-Lara A; Álvarez-Bueno C; Martínez-Vizcaíno V; Notario-Pacheco B; Sequí-Dominguez I; Cavero-Redondo I
    Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32972023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intima-media thickness at different arterial segments in pediatric type 1 diabetes patients and its relationship with advanced glycation end products.
    Lilje C; Cronan JC; Schwartzenburg EJ; Owers EM; Clesi P; Gomez R; Stender S; Hempe J; Chalew SA; Cardinale JP
    Pediatr Diabetes; 2018 May; 19(3):450-456. PubMed ID: 28664608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin autofluorescence (a marker for advanced glycation end products) and erectile dysfunction in diabetes.
    Kouidrat Y; Zaitouni A; Amad A; Diouf M; Desailloud R; Loas G; Lalau JD
    J Diabetes Complications; 2017 Jan; 31(1):108-113. PubMed ID: 27847146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary modulation of advanced glycation end products metabolism on carotid intima-media thickness in type 2 diabetes patients: From the CORDIOPREV study.
    Yubero-Serrano EM; Gutiérrez-Mariscal FM; Gómez-Luna P; Alcalá-Diaz JF; Pérez-Martinez P; López-Miranda J
    Clin Investig Arterioscler; 2023; 35(3):105-114. PubMed ID: 36184301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE.
    Moriya S; Yamazaki M; Murakami H; Maruyama K; Uchiyama S
    J Stroke Cerebrovasc Dis; 2014; 23(10):2540-2546. PubMed ID: 25282185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin autofluorescence, a non-invasive marker for AGE accumulation, is associated with the degree of atherosclerosis.
    den Dekker MA; Zwiers M; van den Heuvel ER; de Vos LC; Smit AJ; Zeebregts CJ; Oudkerk M; Vliegenthart R; Lefrandt JD; Mulder DJ
    PLoS One; 2013; 8(12):e83084. PubMed ID: 24376641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.
    Monnier VM; Sun W; Gao X; Sell DR; Cleary PA; Lachin JM; Genuth S;
    Cardiovasc Diabetol; 2015 Sep; 14():118. PubMed ID: 26341632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Soluble Receptor for Advanced Glycation End Product and Endogenous Secretory Soluble Receptor for Advanced Glycation End Product Levels and Carotid Atherosclerosis in Diabetes: A Systematic Review and Meta-Analysis.
    Wang X; Wang Q; Wei D; Chang X
    Can J Diabetes; 2021 Oct; 45(7):634-640. PubMed ID: 33773934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes.
    Lopes-Virella MF; Hunt KJ; Baker NL; Lachin J; Nathan DM; Virella G;
    Diabetes; 2011 Feb; 60(2):582-9. PubMed ID: 20980456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study.
    Mukai H; Svedberg O; Lindholm B; Dai L; Heimbürger O; Barany P; Anderstam B; Stenvinkel P; Qureshi AR
    Nephrol Dial Transplant; 2019 Mar; 34(3):442-448. PubMed ID: 29378035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.